Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy.
about
The role of ganciclovir for the management of cytomegalovirus retinitis in HIV patients: Pharmacological review and update on new developments.An algorithmic approach to treatment of cytomegalovirus retinitis.Virus infections of the eye.New developments in sustained release drug delivery for the treatment of intraocular diseaseOptimal management of cytomegalovirus retinitis in patients with AIDS.Changing therapeutic paradigms in CMV retinitis in AIDS.Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal.Ganciclovir implant in the treatment of cytomegalovirus retinitis.Local therapy for cytomegalovirus retinitis.High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration.Population differences in ganciclovir clearance as determined by nonlinear mixed-effects modelling.Cytomegalovirus Retinitis in a Human Immunodeficiency Virus-negative Cohort: Long-term Management and Complications.Ring-opening polymerization of ε-caprolactone initiated by ganciclovir (GCV) for the preparation of GCV-tagged polymeric micelles.Inhibition of choroidal neovascularization in rats by the urokinase-derived peptide A6.Cytomegalovirus Treatment.Evolution of Intravitreal Therapy for Retinal Diseases - From CMV to CNV: The LXXIV Edward Jackson Memorial Lecture.Nonparametric expectation maximization population modeling of ganciclovir.A 42-year-old lung transplant patient with ganciclovir-resistant cytomegalovirus (CMV) infection.
P2860
Q33400808-9FA2A542-783F-474C-96BE-7CA32639D8F8Q33569542-756A4992-604A-4AE3-B7A5-78DC671C84C0Q33682990-32638DCA-3A4D-48A8-94A7-9D7105626539Q33760311-599F81BE-BBDB-4423-940E-55A3125F863DQ33819834-7706202F-F1A9-4A52-BAC9-8D065420DA76Q34181810-4C2F3DDD-B029-43ED-BCB3-D6E03EEEB11CQ34670354-00A37D7C-6215-4C0A-A744-8766FAF823ACQ35557331-C6D2F7B9-0E64-4A0D-9710-3001E9697499Q36315123-A115A3FB-CAFF-4D98-B5BA-49276B98E220Q38553191-3F3D84FD-5E92-4515-8D9F-5477058FDC0EQ39716322-2A0D775E-8C6A-4C05-B0B8-F883C8A66486Q39780677-48511526-1A25-457A-8595-0DA820C0D44BQ41437693-9F8FA1B0-09CE-49FE-B9E0-436327AC6B0FQ41487730-B2772810-92D5-444E-B625-E285D4C28A38Q42105130-19E3EAE0-5FCF-4AEF-B46F-E0580C4D2C10Q42554715-9588E212-3C46-47E0-A512-8313F9E3B191Q47729194-08F68634-6596-46C7-8708-5A09F95FB04BQ52307595-366E2E4D-D46F-4912-8BC1-9B89016D2D3EQ54003498-2308E9D7-A59A-4CCD-9346-82DE078108CC
P2860
Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Intravitreal ganciclovir conce ...... tis: implications for therapy.
@en
Intravitreal ganciclovir conce ...... tis: implications for therapy.
@nl
type
label
Intravitreal ganciclovir conce ...... tis: implications for therapy.
@en
Intravitreal ganciclovir conce ...... tis: implications for therapy.
@nl
prefLabel
Intravitreal ganciclovir conce ...... tis: implications for therapy.
@en
Intravitreal ganciclovir conce ...... tis: implications for therapy.
@nl
P2093
P356
P1476
Intravitreal ganciclovir conce ...... tis: implications for therapy.
@en
P2093
Capparelli EV
Flores-Aguilar M
Freeman WR
Kuppermann BD
Quiceno JI
Sherwood CH
P304
P356
10.1093/INFDIS/168.6.1506
P407
P577
1993-12-01T00:00:00Z